Prospective surveillance of Candida auris and assessment of diagnostic approaches in a Belgian hospital
European Journal of Clinical Microbiology & Infectious Diseases · 2026
DOI: 10.1007/s10096-026-05409-4 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Clinical Microbiology & Infectious Diseases, 2026. Verfasst von Kim Callebaut und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Microbiology and Infection Prevention and Control, AZ Sint-Jan Brugge AV, Ruddershove 10, Brugge, 8000, Belgium. Hauptthemen laut MEDLINE: Candidiasis, Candida auris, Candida. Die Arbeit nennt 27 Literaturangaben.
Abstract (Originalsprache)
PURPOSE: Candida auris is an emerging multidrug-resistant fungal pathogen known for its ability to cause healthcare-associated outbreaks. Although only sporadic cases have been reported in Belgium, increasing incidence in Europe highlights the need for early detection strategies. This study aimed to evaluate C. auris colonisation among high-risk patients and assess three detection methods. METHODS: A total of 100 patients were screened using two eSwabs® per patient from: (i) axillae and groins, and (ii) nose, throat and perineum. Culture on CHROMagar Candida plus was compared with two molecular assays: Altostar® Candida auris PCR, and AurisID. Given the overlap in risk factors for C. auris and other multi-drug resistant organisms, the feasibility of culturing C. auris from an enrichment broth containing TSB and 2.5% sodium chloride, often used for MRSA enrichment, was evaluated. RESULTS: Analytical evaluation showed high specificity of the molecular assays with no cross-reactivity to clinically relevant non-target yeasts. Culture on CHROMagar Candida plus appeared more sensitive than both molecular methods. No C. auris carriage was detected among all screened patients. CONCLUSION: Candida auris was not detected in the screened population, indicating a very low or absent prevalence at present. However, surveillance is essential to ensure early recognition and address the risk of future spread.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medical Microbiology and Infection Prevention and Control, AZ Sint-Jan Brugge AV, Ruddershove 10, Brugge, 8000, Belgium.
- Department of Clinical Haematology, AZ Sint-Jan Brugge AV, Ruddershove 10, Brugge, 8000, Belgium.
- Department of Intensive Care Medicine, AZ Sint-Jan Brugge AV, Ruddershove 10, Brugge, 8000, Belgium.
- Department of Medical Microbiology and Infection Prevention and Control, AZ Sint-Jan Brugge AV, Ruddershove 10, Brugge, 8000, Belgium. astrid.muyldermans@azsintjan.be.
Zitieren
APA
Callebaut, K., Hellemans, J., Chin, T., Floré, K., Vanhee, M., Snauwaert, S., Schauwvlieghe, A., Dewulf, B., Reynders, M., & Muyldermans, A. (2026). Prospective surveillance of Candida auris and assessment of diagnostic approaches in a Belgian hospital. European Journal of Clinical Microbiology & Infectious Diseases. https://doi.org/10.1007/s10096-026-05409-4
Vancouver
Callebaut K, Hellemans J, Chin T, Floré K, Vanhee M, Snauwaert S, et al. Prospective surveillance of Candida auris and assessment of diagnostic approaches in a Belgian hospital. European Journal of Clinical Microbiology & Infectious Diseases. 2026. doi:10.1007/s10096-026-05409-4
BibTeX
@article{Callebaut2026,
author = {Callebaut, Kim and Hellemans, Jorn and Chin, Taeyang and Floré, Katelijne and Vanhee, Merijn and Snauwaert, Sylvia and Schauwvlieghe, Alexander and Dewulf, Bram and Reynders, Marijke and Muyldermans, Astrid},
title = {Prospective surveillance of Candida auris and assessment of diagnostic approaches in a Belgian hospital},
journal = {European Journal of Clinical Microbiology & Infectious Diseases},
year = {2026},
doi = {10.1007/s10096-026-05409-4}
}
EUVIMED